Billings Clinic
Especially For:

Clinical Trials

Title   Lung Cancer: CTSU 5508 Stage IIB or IV (1st or 2nd Line)
Description   "CTSU E5508 Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

IRB Number   CTSU 5508
Category   Lung Cancer
Inclusion/Notes   "No prior systemic chemotherapy for advanced stage lung cancer. Prior adjuvant chemotherapy is allowed if at least 12 months have elapsed since the
prior chemotherapy administration and registration. Prior RT ok, no squamous "
Status   Active
Start Date   10/08/2010
Principal Investigator (PI)   Pamela Smith, MD
Contact Name   Judy Miller, RN
Contact Email
Phone   (406) 435-7482
Fax   (000) 000-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.